Research Action for Health Network (REACHnet)

REACHnet, formerly LACDRN (Louisiana Clinical Data Research network), is a partnership that includes Ochsner Health System, Louisiana Public Health Institute, Pennington Biomedical Research Center, LSU Health, PATH (Partnership for Achieving Total Health), Tulane University, and Baylor-Scott & White. It is funded by the Patient-Centered Outcomes Research Institute (PCORI).

Visit the REACHnet webpage.

Co- Principal Investigator:
Eboni G. Price-Haywood, MD, MPH, FACP

Program Manager:
Courtney Parke, PhD

Subprojects

PCSK9i Rapid Cycle Research Project

Goals

  • Characterize the trends and prevalence of use of PCSK9 inhibitor class of medications and other lipid lowering therapies across 8 Patient Centered Outcomes Research networks (PCORnet).
  • Understanding provider types prescribing lipid lowering therapies

Site Co-Investigator: Eboni G. Price-Haywood, MD, MPH, FACP

Real-world treatment patterns and outcomes of patients with T2DM

Goals

  • Evaluate patient treatment pathways, in particular treatment sequences with add-on GLP-1 agonists and insulin after failing initial therapy with oral antidiabetic drugs, and estimate and compare long-term clinical outcomes (i.e. HbA1c, fasting blood glucose, hypoglycemia, weight) of patients with T2DM using different treatment sequences
  • To compare the patient characteristics, clinical outcomes (i.e. HbA1c, hypoglycemia) and daily insulin dose of patients who switched from a basal insulin to insulin degludec and those who switched from a basal insulin to other basal insulins
  • To assess the impact of patient’s weight on diabetes-related resource utilization and diabetes-related macrovascular or microvascular complications (e.g. myocardial infarction, diabetic nephropathy).

Site Co-Investigator: Eboni G. Price-Haywood, MD, MPH, FACP